Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of denosumab on the growing skeleton in osteogenesis imperfecta.

× No keyword cloud information.

9 in total

1. The Changing Sensory and Sympathetic Innervation of the Young, Adult and Aging Mouse Femur.

Authors: Stephane R Chartier; Stefanie A T Mitchell; Lisa A Majuta; Patrick W Mantyh
Journal: Neuroscience Date: 2018-02-10 Impact factor: 3.590

2. Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.

Authors: Ingo Grafe; Stefanie Alexander; Tao Yang; Caressa Lietman; Erica P Homan; Elda Munivez; Yuqing Chen; Ming Ming Jiang; Terry Bertin; Brian Dawson; Franklin Asuncion; Hua Zhu Ke; Michael S Ominsky; Brendan Lee
Journal: J Bone Miner Res Date: 2016-02-12 Impact factor: 6.741

Review 3. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.

Authors: Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Toshihiko Nagata; Masahiro Urade; Takahiko Shibahara; Satoru Toyosawa
Journal: J Bone Miner Metab Date: 2016-12-29 Impact factor: 2.626

9. Novel mutation of FKBP10 in a pediatric patient with osteogenesis imperfecta type XI identified by clinical exome sequencing.

Authors: Harvy Mauricio Velasco; Jessica L Morales
Journal: Appl Clin Genet Date: 2017-11-07

9 in total

Effect of denosumab on the growing skeleton in osteogenesis imperfecta.

1. The Changing Sensory and Sympathetic Innervation of the Young, Adult and Aging Mouse Femur.

2. Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.

Review 3. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.

Review 4. Denosumab: an Emerging Therapy in Pediatric Bone Disorders.

Review 5. Recent developments in osteogenesis imperfecta.

6. Osteogenesis imperfecta: potential therapeutic approaches.

Review 7. Current Overview of Osteogenesis Imperfecta.

8. Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial.

9. Novel mutation of FKBP10 in a pediatric patient with osteogenesis imperfecta type XI identified by clinical exome sequencing.